Tom Brady & Linda Yaccarino on Startup eMed, GLP-1s
Former NFL Quarterback Tom Brady & eMed CEO Linda Yaccarino discuss investment in health startup eMed, soaring GLP-1 weight-loss drug costs, and how to evaluate business opportunities as a well-known former athlete. They speak with Katie Greifeld and Romaine Bostick at the Milken Institute Global Conference in Beverly Hills, California.


_1393629_640x360_2498780739991-640x360.webp&w=3840&q=75)

_1393623_640x360_2498779203990-640x360.webp&w=3840&q=75)
_1393613_640x360_2498782787572-640x360.webp&w=3840&q=75)
_1393598_640x360_2498780227652-640x360.webp&w=3840&q=75)



_1393563_640x360_2498761283721-640x360.webp&w=3840&q=75)